Leadless cardiac pacemaker and retrieval device
US-2015051610-A1 · Feb 19, 2015 · US
US10413733B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10413733-B2 |
| Application number | US-201715791286-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 23, 2017 |
| Priority date | Oct 27, 2016 |
| Publication date | Sep 17, 2019 |
| Grant date | Sep 17, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An implantable medical device (IMD) that includes a housing, a first electrode secured relative to the housing, a second electrode secured relative to the housing, and a gyroscope secured relative to the housing. The IMD may include circuitry in the housing in communication with the first electrode, the second electrode, and the gyroscope. The circuitry may be configured to determine and store a plurality of torsion data measurements, from which a representation of a twist profile may be determined.
Opening claim text (preview).
What is claimed is: 1. A leadless cardiac pacemaker (LCP) configured to sense cardiac activity and to pace a patient's heart, the LCP comprising: a housing; an electrode secured relative to the housing and exposed to an environment outside of the housing; a gyroscope disposed relative to the housing; circuitry in the housing in communication with the electrode and the gyroscope, the circuitry configured to generate a twisting profile over one or more cardiac cycles based at least in part on data obtained from the gyroscope: wherein the circuitry is further configured to: update one or more pacing parameters of the LCP based at least in part on the twisting profile; and pace the patient's heart with the electrode using one or more of the updated pacing parameters. 2. The LCP of claim 1 , wherein the circuitry is configured to update the twisting profile at a predefined regular interval. 3. The LCP of claim 1 , wherein the circuitry is configured to update the twisting profile in response to a detected condition change. 4. The LCP of claim 1 , wherein the detected condition change corresponds to one of exercise, heart failure status, therapy modification, cardiac status, pacing status, or posture. 5. The LCP of claim 1 , wherein updating the one or more pacing parameters of the LCP comprises adjusting an AV delay. 6. The LCP of claim 1 , wherein updating the one or more pacing parameters of the LCP comprises adjusting a VV delay. 7. The LCP of claim 1 , wherein the circuitry is further configured to compare the twisting profile to an additional parameter to determine if the twisting profile is abnormal. 8. The LCP of claim 7 , wherein the additional parameter is one or more of a cardiovascular pressure, a heart sound, an ECG attribute, a blood flow, impedance, respiration, and/or one or more cardiac dimensions. 9. A medical device system, comprising: a first implantable medical device including a gyroscope, the first implantable medical device configured to be secured to a patient's heart; a second medical device in communication with the first implantable medical device; the first implantable medical device and/or the second medical device configured to: determine a twisting profile of the patient's heart based at least in part on data obtained from the gyroscope of the first implantable medical device; adjust one or more therapy parameters of a therapy based at least in part on the twisting profile; and deliver the therapy using one or more of the adjusted therapy parameters. 10. The medical device system of claim 9 , wherein the twisting profile comprises a twist velocity, a twist vector, and a twist angle. 11. The medical device system of claim 9 , wherein the twisting profile provides confirmation of an event detected by the second medical device. 12. The medical device system of claim 9 , wherein the first implantable medical device and/or the second medical device are further configured to update the twisting profile at a predefined regular interval. 13. The medical device system of claim 9 , wherein the first implantable medical device and/or the second medical device are further configured to update the twisting profile in response to a detected condition change. 14. The medical device system of claim 13 , wherein the detected condition change corresponds to one of exercise, heart failure status, or posture. 15. A method for monitoring cardiac dysfunction of a patient's heart using a leadless cardiac pacemaker (LCP) secured to the patient's heart, wherein the LCP includes a housing, an electrode secured relative to the housing and exposed to an environment outside of the housing, and a gyroscope disposed relative to the housing, comprising: delivering a therapy to the patients' heart using the LCP; determining a twisting profile over one or more cardiac cycles based at least in part on data obtained from the gyroscope of the leadless cardiac pacemaker (LCP); adjusting one or more therapy parameters of a therapy for the patient's heart based at least in part on the twisting profile; and delivering the adjusted therapy to the patient's heart using the LCP. 16. The method of claim 15 , wherein the twisting profile includes at least one of a twist angle, a twist vector, and a twist velocity. 17. The method of claim 15 , wherein adjusting one or more therapy parameters comprises adjusting an implant location of the LCP. 18. The method of claim 15 , wherein adjusting one or more therapy parameters comprises adjusting an AV delay. 19. The method of claim 15 , wherein adjusting one or more therapy parameters comprises adjusting a VV delay. 20. The method of claim 15 , wherein adjusting one or more therapy parameters comprises delivering an ATP therapy using the LCP when the twisting profile indicates a tachyarrhythmia that is treatable with ATP therapy.
combined with drug delivery · CPC title
by means inserted into the body · CPC title
Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition · CPC title
Determining haemodynamic parameters not otherwise provided for, e.g. cardiac contractility or left ventricular ejection fraction · CPC title
Casings with electrodes thereon, e.g. leadless stimulators · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.